Trial Profile
Clinical Trials Insight: 700050056
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Oct 2009
Price :
$35
*
At a glance
- Drugs MBX 2982 (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors CymaBay Therapeutics
- 20 Oct 2009 New trial record.
- 13 Oct 2009 Results published in a Metabolex media release.